Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rank in Stocks #18713
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Share Price
$2.49
Market Cap
$4.47M
Change (1 day)
-4.01%
Change (1 year)
678.16%
Country
MY
Trade BioNexus Gene Lab Corporation (BGLC)

Category

Price of BGLC with the market cap of B
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation
BGLC
$2.49
Market Capitalization of BioNexus Gene Lab Corporation(BGLC)
Market Cap: $4.47M
As of March 2026 BioNexus Gene Lab Corporation has a market cap of $4.47M. This makes BioNexus Gene Lab Corporation the world's 18713th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BioNexus Gene Lab Corporation from 2020 to 2026
BGLC compared with Top 5 Most Popular stocks
Price of BGLC Asset B Mkt. of B Results
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation
$2,417,110 $4.47M
$4.343T +97,068,706.65%
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation
$2,066,563 $4.47M
$3.713T +82,991,073.60%
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation
$1,949,782 $4.47M
$3.503T +78,301,269.30%
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation
$1,533,483 $4.47M
$2.755T +61,583,087.55%
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation
$1,264,926 $4.47M
$2.273T +50,798,102.73%